Transbronchial needle aspiration: a diagnostic tool in routine bronchoscopy

Area of Science:

• Pulmonology
• Oncology
• Infectious Diseases

Background:

• Transbronchial Needle Aspiration (TBNA) is a 56-year-old diagnostic technique.
• It is recognized for its efficacy, safety, and cost-effectiveness in specific medical applications.
• Its utility spans diagnosing and staging lung cancer and identifying benign granulomatous conditions like sarcoidosis and tuberculous lymphadenitis.

Purpose of the Study:

• To evaluate the efficacy, safety, and cost-effectiveness of Transbronchial Needle Aspiration (TBNA).
• To discuss factors influencing the sensitivity, accuracy, and utilization of TBNA.
• To propose solutions for improving TBNA accessibility and performance.

Main Methods:

• Review of the established efficacy, safety, and cost-effectiveness of TBNA.
• Analysis of factors affecting TBNA sensitivity and accuracy, including study methods, patient populations, and disease prevalence.
• Consideration of barriers to widespread TBNA adoption, such as cost and training.

Main Results:

• TBNA demonstrates high specificity for diagnosing lung cancer and granulomatous diseases.
• Sensitivity and accuracy can be variable, influenced by methodology, patient factors, and metastasis prevalence.
• Underuse of conventional 'blind' TBNA is attributed to concerns about efficacy, safety, and cost, particularly needle cost in developing countries.

Conclusions:

• TBNA is a valuable tool for diagnosing lung cancer and specific benign conditions.
• Addressing the cost of TBNA needles, potentially through local manufacturing or adaptation to national incomes, is crucial for wider adoption.
• Enhanced training and experience are vital for maximizing TBNA's performance and diagnostic yield.